Paul FreemontView all speakers
Professor Paul Freemont is co-founder and co-director of the EPSRC Centre for Synthetic Biology and Innovation at Imperial College London. The Centre is the first of its kind in the UK and aims to develop an foundational technologies to enable synthetic biology research in application areas like biosensors, bioprocessing, metabolic and genome engineering. Previous to this he was head of the Division of Molecular Biosciences, and head of the Centre for Structural Biology having joined Imperial from Cancer Research UK London Research Institute where he was a Principal Scientist and director of the Macromolecular Structure and Function laboratory.
His research interests focuses on understanding the molecular mechanisms of macromolecular assemblies associated with human disease and is author of over 150 peer-reviewed scientific publications. His research in synthetic biology focuses on in vitro foundational technologies and biosensing. He is co-founder of a spin out company Equinox Pharma Ltd and holds a number of external positions including chair of the Diamond Light Source Scientific Advisory Committee and member MRC Molecular and Cellular Medicines Board.